{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:26:29Z","timestamp":1740108389377,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10096-021-04184-8","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T05:37:54Z","timestamp":1614145074000},"page":"1511-1516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trimethoprim-sulfamethoxazole as de-escalation in ventilator-associated pneumonia: a cohort study subanalysis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0199-3449","authenticated-orcid":false,"given":"Alessio","family":"Strazzulla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Concetta","family":"Postorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracie","family":"Youbong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxence","family":"Rouyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Flateau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Chakvetadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"de Pontfarcy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelia","family":"Pitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Belfeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehran","family":"Monchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Diamantis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"issue":"6","key":"4184_CR1","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.mayocp.2018.11.005","volume":"94","author":"EP Lesho","year":"2019","unstructured":"Lesho EP, Laguio-Vila M (2019) The slow-motion catastrophe of antimicrobial resistance and practical interventions for all prescribers. Mayo Clin Proc 94(6):1040\u20131047. https:\/\/doi.org\/10.1016\/j.mayocp.2018.11.005","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"4184_CR2","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratal\u00e0 J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63(5):e61\u2013e111. https:\/\/doi.org\/10.1093\/cid\/ciw353","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4184_CR3","doi-asserted-by":"publisher","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, Timsit JF, Welte T, Wunderink R (2017) International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latino Americana del T\u00f3rax (ALAT). Eur Respir J 50(3):1700582. https:\/\/doi.org\/10.1183\/13993003.00582-2017","journal-title":"Eur Respir J"},{"issue":"1","key":"4184_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10096-019-03691-z","volume":"39","author":"H Erdem","year":"2020","unstructured":"Erdem H, Cag Y, Gencer S, Uysal S, Karakurt Z, Harman R, Aslan E, Mutlu-Yilmaz E, Karabay O, Uygun Y, Ulug M, Tosun S, Dogru A, Sener A, Dogan M, Hasbun R, Durmus G, Turan H, Batirel A, Duygu F, Inan A, Akkoyunlu Y, Celebi G, Ersoz G, Guven T, Dagli O, Guler S, Meric-Koc M, Oncu S, Rello J (2020) Treatment of ventilator-associated pneumonia (VAP) caused by acinetobacter: results of prospective and multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 39(1):45\u201352. https:\/\/doi.org\/10.1007\/s10096-019-03691-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"4184_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jcrc.2007.12.006","volume":"23","author":"AR Joffe","year":"2008","unstructured":"Joffe AR, Muscedere J, Marshall JC, Su Y, Heyland DK, Canadian Critical Care Trials Group (2008) The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multicenter observational study. J Crit Care 23(1):82\u201390. https:\/\/doi.org\/10.1016\/j.jcrc.2007.12.006","journal-title":"J Crit Care"},{"key":"4184_CR6","volume-title":"Trimethoprim sulfamethoxazole. Stat Pearls [Internet]","author":"TR Kemnic","year":"2018","unstructured":"Kemnic TR, Coleman M (2018) Trimethoprim sulfamethoxazole. Stat Pearls [Internet]. Stat Pearls Publishing, Treasure Island (FL)"},{"issue":"11","key":"4184_CR7","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s10096-019-03656-2","volume":"38","author":"A Strazzulla","year":"2019","unstructured":"Strazzulla A, Postorino MC, Purcarea A, Chakvetadze C, de Farcy de Pontfarcy A, Tebano G, Pitsch A, Vong L, Jochmans S, Vinsonneau C, Monchi M, Diamantis S (2019) Trimetoprim-sulfametoxazole in ventilator-associated pneumonia: a cohort study. Eur J Clin Microbiol Infect Dis 38(11):2163\u20132169. https:\/\/doi.org\/10.1007\/s10096-019-03656-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4184_CR8","unstructured":"Journal officiel de la R\u00e9publique Fran\u00e7aise. LOI n 2012-300 du 5 mars 2012 relative aux recherches impliquant la personne humaine (1). Available at https:\/\/www.legifrance.gouv.fr\/affichTexte.do?cidTexte=JORFTEXT000025441587&categorieLien=id (French, last accessed on April 9th, 2020)"},{"issue":"1","key":"4184_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.therap.2016.12.006","volume":"72","author":"D Deplanque","year":"2017","unstructured":"Deplanque D, S\u00e9n\u00e9chal-Cohen S, Lemaire F (2017) Participants of Giens XXXII, round table n(o) 5. French Jard\u00e9's law and European regulation on drug trials: Harmonization and implementation of new rules. Th\u00e9rapie. 72(1):73\u201380. https:\/\/doi.org\/10.1016\/j.therap.2016.12.006","journal-title":"Th\u00e9rapie."},{"issue":"3","key":"4184_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccm.2011.06.001","volume":"32","author":"DE Craven","year":"2011","unstructured":"Craven DE, Hudcova J, Lei Y (2011) Diagnosis of ventilator-associated respiratory infections (VARI): microbiologic clues for trachea bronchitis (VAT) and pneumonia (VAP). Clin Chest Med 32(3):547\u2013557. https:\/\/doi.org\/10.1016\/j.ccm.2011.06.001","journal-title":"Clin Chest Med"},{"key":"4184_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/1471-2334-13-561","volume":"13","author":"AA Quartin","year":"2013","unstructured":"Quartin AA, Scerpella EG, Puttagunta S, Kett DH (2013) A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect Dis 13:561. https:\/\/doi.org\/10.1186\/1471-2334-13-561","journal-title":"BMC Infect Dis"},{"issue":"11","key":"4184_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A (2013) Kidney disease: improving global outcomes chronic kidney disease guideline development work group members: evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guidelines. Ann Intern Med 158(11):825\u2013830. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007","journal-title":"Ann Intern Med"},{"issue":"3","key":"4184_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/TA.0b013e31811ec18e","volume":"64","author":"TL Hedrick","year":"2008","unstructured":"Hedrick TL, Smith RL, McElearney ST, Evans HL, Smith PW, Pruett TL, Young JS, Sawyer RG (2008) Differences in early- and late-onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit. J Trauma 64(3):714\u2013720. https:\/\/doi.org\/10.1097\/TA.0b013e31811ec18e","journal-title":"J Trauma"},{"issue":"8","key":"4184_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 315(8):801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA."},{"key":"4184_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2019.00262","volume":"10","author":"B Gao","year":"2019","unstructured":"Gao B, Li X, Yang F, Chen W, Zhao Y, Bai G, Zhang Z (2019) Molecular epidemiology and risk factors of ventilator-associated pneumonia infection caused by carbapenem-resistant enterobacteriaceae. Front Pharmacol 10:262. https:\/\/doi.org\/10.3389\/fphar.2019.00262","journal-title":"Front Pharmacol"},{"issue":"4","key":"4184_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ijantimicag.2018.12.001","volume":"53","author":"S Abbara","year":"2019","unstructured":"Abbara S, Pitsch A, Jochmans S, Hodjat K, Cherrier P, Monchi M, Vinsonneau C, Diamantis S (2019) Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit. Int J Antimicrob Agents 53(4):416\u2013422. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.12.001","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"4184_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4103\/0366-6999.231529","volume":"131","author":"H Li","year":"2018","unstructured":"Li H, Yang CH, Huang LO, Cui YH, Xu D, Wu CR, Tang JG (2018) Antibiotics de-escalation in the treatment of ventilator-associated pneumonia in trauma patients: a retrospective study on propensity score matching method. Chin Med J 131(10):1151\u20131157. https:\/\/doi.org\/10.4103\/0366-6999.231529","journal-title":"Chin Med J"},{"issue":"4","key":"4184_CR18","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s11096-017-0499-2","volume":"39","author":"RA Khan","year":"2017","unstructured":"Khan RA, Aziz Z (2017) A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia. Int J Clin Pharm 39(4):906\u2013912. https:\/\/doi.org\/10.1007\/s11096-017-0499-2","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"4184_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1097\/TA.0b013e31819dca4e","volume":"66","author":"SR Eachempati","year":"2009","unstructured":"Eachempati SR, Hydo LJ, Shou J, Barie PS (2009) Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? J Trauma 66(5):1343\u20131348. https:\/\/doi.org\/10.1097\/TA.0b013e31819dca4e","journal-title":"J Trauma"},{"issue":"9","key":"4184_CR20","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s00134-007-0619-x","volume":"33","author":"E Giantsou","year":"2007","unstructured":"Giantsou E, Liratzopoulos N, Efraimidou E, Panopoulou M, Alepopoulou E, Kartali-Ktenidou S, Manolas K (2007) De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med 33(9):1533\u20131540. https:\/\/doi.org\/10.1007\/s00134-007-0619-x","journal-title":"Intensive Care Med"},{"issue":"1","key":"4184_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1055\/s-2006-933673","volume":"27","author":"MS Niederman","year":"2006","unstructured":"Niederman MS (2006) The importance of de-escalating antimicrobial therapy in patients with ventilator-associated pneumonia. Semin Respir Crit Care Med 27(1):45\u201350. https:\/\/doi.org\/10.1055\/s-2006-933673","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"4184_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/1060028017730838","volume":"52","author":"GC Wood","year":"2018","unstructured":"Wood GC, Jonap BL, Maish GO 3rd, Magnotti LJ, Swanson JM, Boucher BA, Croce MA, Fabian TC (2018) Treatment of achromobacter ventilator-associated pneumonia in critically ill trauma patients. Ann Pharmacother 52(2):120\u2013125. https:\/\/doi.org\/10.1177\/1060028017730838","journal-title":"Ann Pharmacother"},{"issue":"1","key":"4184_CR23","doi-asserted-by":"publisher","first-page":"ofy351","DOI":"10.1093\/ofid\/ofy351","volume":"6","author":"CL Luterbach","year":"2018","unstructured":"Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D (2018) The role of trimethoprim\/sulfamethoxazole in the treatment of infections caused by carbapenem-resistant enterobacteriaceae. Open Forum Infect Dis 6(1):ofy351. https:\/\/doi.org\/10.1093\/ofid\/ofy351","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"4184_CR24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/jac\/dkw510","volume":"72","author":"N Eliakim-Raz","year":"2017","unstructured":"Eliakim-Raz N, Hellerman M, Yahav D, Cohen J, Margalit I, Fisher S, Zusman O, Shaked H, Bishara J (2017) Trimethoprim\/sulfamethoxazole versus vancomycin in the treatment of healthcare\/ventilator-associated MRSA pneumonia: a case-control study. J Antimicrob Chemother 72(3):882\u2013887. https:\/\/doi.org\/10.1093\/jac\/dkw510","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"4184_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.18683\/germs.2018.1140","volume":"8","author":"N El Sayed","year":"2018","unstructured":"El Sayed N, Ashour M, Amine AEK (2018) Vancomycin resistance among Staphylococcus aureus isolates in a rural setting. Egypt Germs 8(3):134\u2013139. https:\/\/doi.org\/10.18683\/germs.2018.1140","journal-title":"Egypt Germs"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04184-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T13:06:52Z","timestamp":1623762412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04184-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4184"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04184-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"assertion":[{"value":"17 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Because this study did not require neither further laboratory analysis nor different clinical acts than daily clinical routine, a written consent form was not proposed to any eligible patients","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}